Target intelligence / Profile preview

Genomic DNA adenines susceptible to residual TadA-derived off-target deamination

Molecular classification
Nucleic acid, DNA
01

Overview

Genomic DNA adenines susceptible to residual TadA-derived off-target deamination are specific nucleotide positions within the genome where Adenine Base Editors (ABEs) cause unintended A-to-G transitions. ABEs utilize an evolved tRNA-specific adenosine deaminase (TadA) fused to a CRISPR-Cas protein to perform targeted base editing [1]. However, the TadA domain can exhibit stochastic, guide-independent activity on single-stranded DNA (ssDNA) exposed during processes like transcription or replication [2]. This results in the conversion of adenosine to inosine, which is subsequently read as guanosine by DNA polymerases, creating permanent mutations [3]. These off-target events are a major concern in gene therapy because they can occur at high frequencies across the genome, potentially leading to the disruption of tumor suppressor genes or the activation of oncogenes [4]. Efforts to mitigate this include the engineering of high-fidelity TadA variants with reduced ssDNA affinity and the use of sensitive detection assays like Digenome-seq or GOTI to monitor genomic integrity [5].

Other names
Off-target DNA adenine sitesABE-mediated off-target sitesTadA-dependent DNA off-targetssgRNA-independent ABE off-targetsResidual TadA activity sites
02

Mechanism of action

Deamination of adenosine to inosine by TadA-derived enzymes, resulting in A-to-G transitions during DNA replication or repair.

03

Biological functions

Genetic information storage
04

Disease associations

CancerGenetic disorders
05

Safety considerations

Unintended genomic mutationsGenotoxicityPotential oncogenesisLoss of function in essential genesTranscriptome-wide RNA off-target editing
06

Interacting drugs

Adenine Base Editors (ABEs)

1 more in the full profile.

07

Biomarkers

A-to-G transition mutationsInosine presence in DNADigenome-seq signaturesGOTI (Genome-wide Off-target analysis by Intercellular genetic substitution) signals

Beyond the preview

Go deeper on Genomic DNA adenines susceptible to residual TadA-derived off-target deamination.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Genomic DNA adenines susceptible to residual TadA-derived off-target deamination.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call